The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Designer DNA nanostructures for therapeutics
Open accessAbstract
Summary The field of structural DNA nanotechnology applies the programmability of Watson-Crick base pairing to the construction of custom nanostructures that are prescribed by the sequence information encoded in DNA molecules. Precisely defined geometries, highly programmable molecular interactions, and outstanding biocompatibility make DNA nanostructures a new category of nanocarriers for drug delivery. Over the past decade, the potential of using DNA nanocarrier-based formulation for cancer therapy has been extensively explored with the successful implementation of various therapeutic strategies, both in vitro and in vivo. Moreover, DNA nanocarriers can be encoded with complex instructions via sequence design, enabling therapeutic functions to be executed in a programmed, automatic manner. In this review, we summarize recent advances and discuss the challenges and opportunities in designer DNA nanostructure-enabled therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Design and self-assembly of two-dimensional DNA crystals
Winfree, E., Liu, F., Wenzler, L. A., & Seeman, N. C. (1998) · Nature · doi:10.1038/28998 · Cited by 2,857
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Seeman, N. C., & Sleiman, H. F. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.68 · Cited by 1,875
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Challenges and opportunities for structural DNA nanotechnology
Pinheiro, A. V., Han, D., Shih, W. M., & Yan, H. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.187 · Cited by 1,292
Self-citationA 1.7-kilobase single-stranded DNA that folds into a nanoscale octahedron
Shih, W. M., Quispe, J. D., & Joyce, G. F. (2004) · Nature · doi:10.1038/nature02307 · Cited by 989
Self‐assembled DNA nanoclews for the efficient delivery of CRISPR–Cas9 for genome editing
Sun, W., Ji, W., Hall, J. M., Hu, Q., Wang, C., Beisel, C. L., & Gu, Z. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506030 · Cited by 629
DNA nanotechnology from the test tube to the cell
Chen, Y.-J., Groves, B., Muscat, R. A., & Seelig, G. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.195 · Cited by 594
Cited by
Guselnikova, O., Lim, H., Kim, H., Kim, S. H., Gorbunova, A., Eguchi, M., Postnikov, P., Nakanishi, T., Asahi, T., Na, J., et al. (2022) · Small · doi:10.1002/smll.202107182 · Cited by 263
Metadata
- Authors
- Jiang, S., Ge, Z., Mou, S., Yan, H., & Fan, C.
- Venue
- Chem
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 7
- Issue
- 5
- Pages
- 1156-1179
- ISSN
- 2451-9294 (ISSN-L)
- OpenAlex
- W3104424379
- Cited by
- 171
- References
- 14
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Designer DNA nanostructures for therapeutics. https://app.cochat.ai/papers/10.1016/j.chempr.2020.10.025
- The paper
- Jiang, S., Ge, Z., Mou, S., Yan, H., & Fan, C. (2021). Designer DNA nanostructures for therapeutics. Chem. https://doi.org/10.1016/j.chempr.2020.10.025
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.